ElvaInvestors

We built this in a few months, and we're just getting started.

Elva is a fast-growing life and wellness brand spanning weight loss, peptide therapy, mental health, and more. This is a short screening quiz, if you qualify, you'll see the full deal terms and can request a call with our founder.

£1.08M
ARR run-rate (trailing 30 days)
+40%
Revenue growth, last 30 days vs prior 30
Step 1 of 7

What type of investor are you?

This just helps us prep for the call.

Traction

Real numbers, pulled straight from our own systems.

£0.00M
ARR run-rate (trailing 30 days)
+0%
Revenue growth, last 30 days vs prior 30
Product

One brand, several verticals.

Weight loss made easy with personalised care.

Real support, real progress. Eligibility check in 2 minutes, care plan, and shipping handled end-to-end.

Treatment when clinically appropriate
1:1 clinician guidance throughout
Free dietitian visits & nutrition coaching
24/7 in-app support
Free, fast delivery
Live now
Coming soon to the core catalog
ElvaLongevity

A broader peptide range beyond weight loss, using the same clinical intake and dosing infrastructure.

Coming soon
B2B & wholesale
ElvaResearch

Research and wholesale supply for partners and institutions.

Live now
Mental health care, without the wait
ElvaTherapy

Therapy built for real life, not a waiting list.

Talk therapy with a real therapist, matched to what you're actually dealing with, not a generic intake form. Video, phone or message sessions that fit around your week, with no long wait to get started.

Real therapists, matched to what you need
Individual, couples, or teen therapy
Video, phone, or message sessions, your choice
First session within days, not weeks
Joined up with your other Elva care plans
Coming soon
Care designed for women's health

Whole-body care for her balance, vitality, and confidence.

From hormones and cycle to menopause and metabolism. Care plans designed around how a woman's body actually works.

Hormone & cycle support
Healthy weight management
Hair strength & growth support
Skin health & radiance
Fast & discreet shipping
Coming soon
Care for energy, hormones, and performance

Men's healthcare, built for men who expect more.

Expert-guided care for hormones, energy and performance. Treatment plans tailored to your goals and adjusted as your body responds.

Physical performance
Hormone balance
Energy & mental focus
Hair & sexual health support
Fast & discreet shipping
Coming soon
Built for life on GLP-1

Fuel your transformation with GLP-friendly meals.

Smaller appetite, bigger demands. GLP-1 changes how much you eat, so what you eat has to work harder. Protein-led plans that protect lean muscle, sit gently when nausea hits, and keep your results compounding week after week.

High-protein meals built to preserve lean muscle on a smaller appetite
Low-volume, nutrient-dense plates designed for GLP-1 satiety
Gentle options for the days when nausea or appetite loss hits hardest
Free dietitian consultations alongside your treatment plan
Tracked through your titration, not a one-size template
Coming soon
Cover that understands your treatment
ElvaInsure

Insurance built for everyday life in progress.

Specialised cover from Elva's insurance partners, designed for people managing real health journeys, not just ticking boxes on a standard form.

Underwriting that accounts for treatment, not just diagnosis
Partnered insurers experienced with GLP-1 and weight-loss care
Straightforward applications, no jargon
Support if your circumstances change
Coming soon
Advanced peptide & longevity support

Targeted support for recovery, performance, and longevity.

Peptide therapy designed to support how your body recovers, performs and repairs. Clinically dosed, expert overseen.

Recovery & performance support
Sleep & energy optimisation
Targeted protocols, not one-size-fits-all
Expert-guided dosing
Coming soon

Think you're a fit?

Take the two-minute screening quiz above. If you qualify, you'll see full deal terms and can request time with our founder.

Elva HomeContactTermsPrivacy

© 2026 Elva. This page and the figures on it are provided for general information only. Deal terms, figures, and legal disclaimers are governed in English and GBP; converted amounts are approximate, for convenience only.

Capital is at risk. This is a high-level summary only and does not constitute a prospectus, financial promotion, or offer of securities to the public. It is provided only to persons who have self-certified as a certified high net worth investor, self-certified sophisticated investor, certified sophisticated investor, or professional / institutional investor under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.

This offering has not been registered, approved, or licensed by any regulator, and this page is not directed at, and must not be relied upon by, persons in any jurisdiction where doing so would be unlawful. It is the recipient's sole responsibility to determine whether they are permitted to receive this information and consider this opportunity under the laws of their home jurisdiction, and to obtain any consent, approval, or licence required to do so.

United States: this page and any related materials have not been, and will not be, registered under the U.S. Securities Act of 1933. Any offer or sale to U.S. persons would be made only to accredited investors as defined in Rule 501 of Regulation D, and only pursuant to definitive offering documentation.

European Union: this page does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129 and has not been approved by any EU regulator. Any offer to EU-based investors is made only to persons who qualify as professional or qualified investors under applicable national law.

Singapore: this page has not been, and will not be, lodged or registered as a prospectus with the Monetary Authority of Singapore. Any offer is made only in reliance on exemptions available to accredited or institutional investors under the Securities and Futures Act 2001.

Hong Kong: this page has not been reviewed or approved by the Securities and Futures Commission. Any offer is made only to professional investors as defined in the Securities and Futures Ordinance (Cap. 571).

Middle East, Asia-Pacific, and all other jurisdictions: this offering is not registered or licensed with any local regulator. Recipients based outside the UK, US, EU, Singapore, or Hong Kong are solely responsible for satisfying themselves that they may lawfully consider this opportunity under their own local laws before proceeding.

Early-stage investments carry a high risk of loss, including total loss of capital, may be illiquid, and there is no guarantee of any return. Nothing here is financial, legal, or tax advice. Please seek independent professional advice, including advice specific to your jurisdiction, before making any investment decision. Full terms will be confirmed in definitive legal documentation, which will govern in the event of any conflict with this summary.